0000000001253708

AUTHOR

C. Fourmont

showing 7 related works from this author

Unexpected adverse effect of metyrapone: A case report

2018

medicine.medical_specialtyMetyraponebusiness.industryEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismmedicine.disease03 medical and health sciences0302 clinical medicineEndocrinologyEndocrinologyInternal medicinemedicineAdverse effectbusinessRhabdomyolysis030217 neurology & neurosurgerymedicine.drugClinical Endocrinology
researchProduct

Effet secondaire inattendu de la métyrapone : à propos d’un cas

2018

Introduction L’hypercorticisme est une pathologie rare et l’utilisation de la metyrapone est peu frequente. Le surdosage en metyrapone se traduit habituellement par des symptomes gastro-intestinaux et une insuffisance surrenalienne aigue. Observation Un diagnostic d’hypercorticisme est realise chez un homme de 28 ans. Un traitement par metyrapone 250 mg deux fois par jour a debute pour controler l’hypercorticisme. Le patient est hospitalise pour une intoxication medicamenteuse volontaire avec 100 comprimes de metyrapone. Un diagnostic d’insuffisance surrenalienne aigue est pose devant des douleurs abdominales, des vomissements, une asthenie et une hypotension. Il ne presente pas de myalgies…

EndocrinologyEndocrinology Diabetes and MetabolismGeneral MedicineAnnales d'Endocrinologie
researchProduct

Type 1 diabetes is not associated with an increased prevalence of hepatic steatosis

2015

Aim Non-alcoholic fatty liver disease (NAFLD) is commonly associated with Type 2 diabetes. Recently, it has been suggested that NAFLD is also frequently associated with Type 1 diabetes and diabetic complications. In this study, we set out to determine whether Type 1 diabetes was associated with liver fat content measured using magnetic resonance imaging. Methods One hundred and twenty-eight patients with Type 1 diabetes, 264 patients with Type 2 diabetes and 67 participants without diabetes were included in this study. Hepatic steatosis was defined as a liver fat content > 5.5%. Results People with Type 1 diabetes and controls were similar for age and BMI. Liver fat content was significantl…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismGastroenterologyBody Mass IndexEndocrinologyNon-alcoholic Fatty Liver DiseaseRisk FactorsInternal medicineDiabetes mellitusPrevalenceInternal MedicineHumansMass ScreeningMedicineObesityProspective StudiesProspective cohort studyMass screeningAgedType 1 diabetesbusiness.industryFatty liverAge FactorsMiddle AgedOverweightmedicine.diseaseMagnetic Resonance ImagingDiabetes Mellitus Type 1Diabetes Mellitus Type 2LiverIntima-media thicknessFemaleFranceSteatosisbusinessBody mass indexDiabetic Medicine
researchProduct

Liver Fat Content in People with Pituitary Diseases: Influence of Serum IGF1 Levels

2017

AbstractNon-alcoholic fatty liver disease (NAFLD) is commonly associated with obesity, metabolic syndrome, and type 2 diabetes. NAFLD is also seen in patients with endocrinopathies. However, the relationship between endocrine diseases and the development of NAFLD is not well known. In this study, we set out to determine whether liver fat content (LFC) was associated with IGF1 levels in people with pituitary diseases (PD). Eighty-nine patients with pituitary diseases and 74 healthy controls were included in this study. LFC was measured using MRI. Hepatic steatosis was defined as LFC>5.5%. Patients with PD were older, and had a higher BMI than healthy controls. LFC was significantly higher…

0301 basic medicineAdultMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismClinical Biochemistry030209 endocrinology & metabolismDiseaseType 2 diabetesIntra-Abdominal FatBiochemistryBody Mass Index03 medical and health sciences0302 clinical medicineEndocrinologyInternal medicine[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyLiver fatmedicinesteatosisEndocrine systemHumansProspective StudiesInsulin-Like Growth Factor Ibusiness.industryBiochemistry (medical)Fatty liverIGF1pituitary diseasesnon-alcoholic fatty liver diseaseGeneral MedicineMiddle Agedmedicine.diseaseObesity030104 developmental biologyEndocrinologyCase-Control StudiesFemaleSteatosisMetabolic syndromebusinessBiomarkers
researchProduct

Fewer Type A personality traits in type 2 diabetes patients with diabetic foot ulcer.

2021

Abstract Aim Type A personality—characterized by time urgency, strong drive, and a need for achievement and competitiveness—has been shown to be associated with reduced mortality in patients with diabetes. However, it is not known whether a Type A personality might protect against diabetic foot ulcer (DFU). This prompted our present analysis of the association between Type A personality and DFU. Methods The Bortner Scale questionnaire was used to assess Type A personality in 386 patients with type 2 diabetes (T2D), including 104 patients also presenting with, and 282 presenting without, DFU. Additional questionnaires were used to assess perceived stress and depression. Results Type A Bortne…

medicine.medical_specialtyMultivariate analysisEndocrinology Diabetes and Metabolismmedia_common.quotation_subject030209 endocrinology & metabolismType 2 diabetes030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineEndocrinologyRisk FactorsDiabetes mellitusInternal medicineInternal MedicinePrevalenceMedicinePersonalityHumansIn patientDepression (differential diagnoses)media_commonbusiness.industryType A and Type B personality theoryType A PersonalityGeneral Medicinemedicine.diseaseDiabetic FootDiabetic foot ulcerDiabetes Mellitus Type 2businessDiabetesmetabolism
researchProduct

Feasibility and Preliminary Results of an Ambutatory Educational Program for the Use of Fsl in 359 Insulin-Treated Patients

2018

[SDV.MHEP.EM] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism
researchProduct

Effet secondaire inattendu de la métyrapone : à propos d’un cas

2018

[SDV.MHEP.EM] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismRhabdomyolyseMétyrapone
researchProduct